The sale appears to be part of a pre-existing 10b5-1 plan given the pattern of prior sales in August and September 2026. Monitor for any acceleration of insider selling beyond the plan or for any material non-public information that may have prompted the filing.
Price Chart
Executive Summary
Thomas Catinazzo, an officer of Relay Therapeutics, filed a Form 144 notice of intent to sell up to 93,153 shares of common stock, with an approximate market value of $1.81 million based on the filing date. The shares were acquired through vesting of restricted and performance stock units between January 2025 and January 2026. The filing also notes prior 10b5-1 plan sales in August and September 2026, suggesting this is part of a pre-arranged trading program rather than a discretionary insider sale.
Key Facts
- Officer Thomas Catinazzo filed Form 144 to sell 93,153 shares of common stock.
- Estimated aggregate market value of the proposed sale is $1,806,236.67 based on the filing date.
- Shares were acquired via vesting of restricted and performance stock units from January 2025 to January 2026.
- Prior 10b5-1 plan sales occurred on August 14, 2026 (17,717 shares) and September 8, 2026 (17,717 shares).
- The filing is an advance notice of intent to sell; actual sale may not occur.
Financial Impact
Proposed sale of 93,153 shares valued at approximately $1.81 million, representing roughly 0.04% of the company's market cap based on the filing date.
Risk Factors
- Insider selling may signal lack of confidence if not part of a pre-arranged plan.
- The company is a pre-revenue biotech; any insider sale could be viewed negatively by the market.
- Form 144 is only an intent to sell; the actual sale may not occur or may be at different prices.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010071 |
| Document: 0001950047-26-010071-index.html | 0001950047-26-010071 |
| Document: 0001950047-26-010071.txt | 0001950047-26-010071 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 21d ago | 144 | $17.41 | awaiting T+60 | awaiting T+60 | $19.42 (+11.52%) |
Oct 6, 2026 22d ago | 144 | $17.95 | awaiting T+60 | awaiting T+60 | $19.42 (+8.16%) |
Sep 9, 2026 7w ago | Insider Cluster | $18.89 | awaiting T+60 | awaiting T+60 | $19.42 (+2.78%) |
Aug 28, 2026 8w ago | Insider Cluster | $18.77 | awaiting T+60 | awaiting T+60 | $19.42 (−3.44%) |
Aug 18, 2026 10w ago | Insider Cluster | $20.74 | awaiting T+60 | awaiting T+60 | $19.42 (+6.39%) |
Jul 8, 2026 16w ago | Insider Cluster | $20.75 $18.96 | ▼ −8.63% | ▼ −11.01% | $19.42 (−6.43%) |
Jun 22, 2026 18w ago | 144 | $17.44 $18.84 | ▲ +8.03% | ▲ +4.78% | $19.42 (+11.32%) |
Jun 12, 2026 19w ago | Institutional Cluster | $14.81 $19.11 | ▲ +29.03% | ▲ +25.77% | $19.42 (+31.09%) |
May 21, 2026 22w ago | 8-K | $13.53 $20.61 | ▼ −52.33% | ▼ −49.14% | $19.42 (−43.50%) |
May 20, 2026 23w ago | Press Release | $13.66 $20.67 | ▼ −51.32% | ▼ −47.02% | $19.42 (−42.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers